PTHrP also contributes to the pathophysiology of breast cancer through its actions on tumor cells themselves, on the tumor microenvironment and on bone cells to promote the development of osteolytic bone metastases [24], [25], [26], [27]. The gene discussed is PTHLH; the disease is breast carcinoma.